Great West Life Assurance CO Blueprint Medicines Corp Transaction History

Great West Life Assurance CO

$63.1 Billion
Q2 2025

A detailed history of Great West Life Assurance CO transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Great West Life Assurance CO holds 14,186 shares of BPMC stock, worth $1.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,186

Previous 7,621 86.14%

Holding current value

$1.84 Million

Previous $676,000 169.53%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$79.22 - $128.4 $520,079 - $842,946	6,565 Added 86.14%	14,186 $1.82 Million
Q1 2025 May 15, 2025	BUY	$86.69 - $115.63 $121,452 - $161,997	1,401 Added 22.52%	7,621 $676,000
Q4 2024 Feb 13, 2025	SELL	$82.48 - $101.39 $110,935 - $136,369	-1,345 Reduced 17.78%	6,220 $541,000
Q3 2024 Nov 13, 2024	BUY	$84.1 - $120.5 $24,557 - $35,186	292 Added 4.01%	7,565 $700,000
Q2 2024 Aug 12, 2024	BUY	$85.18 - $108.78 $37,394 - $47,754	439 Added 6.42%	7,273 $785,000
Q1 2024 May 13, 2024	BUY	$73.17 - $99.79 $18,731 - $25,546	256 Added 3.89%	6,834 $648,000
Q4 2023 Feb 13, 2024	SELL	$43.96 - $92.84 $577,238 - $1.22 Million	-13,131 Reduced 66.62%	6,578 $603,000
Q3 2023 Nov 14, 2023	BUY	$46.9 - $66.0 $180,752 - $254,364	3,854 Added 24.31%	19,709 $988,000
Q2 2023 Aug 10, 2023	BUY	$42.2 - $66.37 $46,124 - $72,542	1,093 Added 7.4%	15,855 $1.01 Million
Q1 2023 May 12, 2023	BUY	$37.97 - $50.0 $113 - $150	3 Added 0.02%	14,762 $665,000
Q4 2022 Feb 10, 2023	BUY	$41.06 - $66.48 $226,692 - $367,036	5,521 Added 59.76%	14,759 $650,000
Q3 2022 Nov 01, 2022	BUY	$49.93 - $77.7 $461,253 - $717,792	9,238 New	9,238 $608,000
Q2 2022 Aug 09, 2022	BUY	$45.23 - $70.15 $4,206 - $6,523	93 Added 3.13%	3,069 $155,000
Q1 2022 May 12, 2022	SELL	$54.1 - $110.08 $8,980 - $18,273	-166 Reduced 5.28%	2,976 $202,000
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $8,199 - $10,091	87 Added 2.85%	3,142 $335,000
Q2 2021 Aug 11, 2021	SELL	$82.78 - $101.0 $22,102 - $26,967	-267 Reduced 8.04%	3,055 $269,000
Q1 2021 May 17, 2021	SELL	$90.71 - $108.28 $39,186 - $46,776	-432 Reduced 11.51%	3,322 $321,000
Q4 2020 Feb 16, 2021	BUY	$92.08 - $124.48 $42,264 - $57,136	459 Added 13.93%	3,754 $420,000
Q3 2020 Nov 17, 2020	SELL	$66.45 - $92.7 $106,652 - $148,783	-1,605 Reduced 32.76%	3,295 $305,000
Q3 2020 Nov 13, 2020	BUY	$66.45 - $92.7 $106,652 - $148,783	1,605 Added 48.71%	4,900 $454,000
Q4 2019 Feb 11, 2020	BUY	$66.73 - $82.59 $19,084 - $23,620	286 Added 9.5%	3,295 $263,000
Q3 2019 Oct 25, 2019	SELL	$72.9 - $101.41 $155,495 - $216,307	-2,133 Reduced 41.48%	3,009 $221,000
Q2 2019 Jul 31, 2019	SELL	$73.54 - $97.8 $58,611 - $77,946	-797 Reduced 13.42%	5,142 $0
Q1 2019 May 08, 2019	BUY	$48.7 - $86.6 $48,797 - $86,773	1,002 Added 20.3%	5,939 $474,000
Q1 2018 May 10, 2018	BUY	$73.28 - $102.95 $117,614 - $165,234	1,605 Added 48.17%	4,937 $453,000
Q3 2017 Nov 09, 2017	BUY	$42.37 - $69.67 $141,176 - $232,140	3,332	3,332 $228,000

Others Institutions Holding BPMC

# of Institutions

350

Shares Held

65.9M

Call Options Held

973K

Put Options Held

1.54M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $7.73B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Blueprint Medicines Corp Transaction History